Metraipolis › archive › dc_63f01db1fadd

Systematic bioinformatics analysis identifies shikonin as a novel mTOR pathway inhibitor in triple-negative breast cancer progression — Europe PMC PMID:40949144

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40949144
DOI
10.3389/fphar.2025.1603093
License (as archived)
solo-consultazione
Archived
2026-11-10T06:45:11.983Z
SHA-256 of the archived text
74fb2707da94daa0b6e5c4ecc2c33abd0d25da287d2cdf262665bb7fd75283ea
Stable URL of this page
https://metraipolis.com/documento/dc_63f01db1fadd

How to cite

Systematic bioinformatics analysis identifies shikonin as a novel mTOR pathway inhibitor in triple-negative breast cancer progression — Europe PMC PMID:40949144 — Europe PMC (en), https://europepmc.org/article/MED/40949144 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_63f01db1fadd (Metraipolis archive dc_63f01db1fadd, sha256 74fb2707da94daa0b6e5c4ecc2c33abd0d25da287d2cdf262665bb7fd75283ea)
BibTeX
@misc{dc63f01db1fadd,
  title = {Systematic bioinformatics analysis identifies shikonin as a novel mTOR pathway inhibitor in triple-negative breast cancer progression — Europe PMC PMID:40949144},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40949144},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_63f01db1fadd; sha256 74fb2707da94daa0b6e5c4ecc2c33abd0d25da287d2cdf262665bb7fd75283ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40949144. Agents can read the archived copy with the MCP tool read_document.